Results 101 to 110 of about 3,282 (184)

A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II) [PDF]

open access: gold
Kenichi Suzuki   +14 more
openalex   +1 more source

Successful re-administration after nano-liposomal irinotecan-induced severe hypersensitivity reaction: a case report. [PDF]

open access: yesJ Pharm Health Care Sci
Kanno R   +5 more
europepmc   +1 more source

Expert Consensus Guidance on the Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective. [PDF]

open access: yesCureus
Dhabhar B   +10 more
europepmc   +1 more source

Palonosetron Improves Dietary Intake Compared to Granisetron in Patients Undergoing Highly Emetogenic Chemotherapy [PDF]

open access: bronze, 2013
Nobuhiro Shibata   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy